<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: independent associates", fill: "#b19cd9"},
{source: "2: independent associates", target: "5: factors affect", fill: "#324ab2"},
{source: "5: factors affect", target: "5: significant", fill: "#324ab2"},
{source: "5: significant", target: "5: independent associates", fill: "#324ab2"},
{source: "5: independent associates", target: "5: ongoing motivation", fill: "#324ab2"},
{source: "5: ongoing motivation", target: "5: general economic conditions", fill: "#324ab2"},
{source: "5: general economic conditions", target: "5: commissions paid", fill: "#324ab2"},
{source: "5: commissions paid", target: "5: public perception", fill: "#324ab2"},
{source: "5: public perception", target: "5: acceptance", fill: "#324ab2"},
{source: "5: acceptance", target: "5: wellness industry", fill: "#324ab2"},
{source: "5: wellness industry", target: "5: Contents ", fill: "#324ab2"},
{source: "5: Contents ", target: "5: Financial Statements ", fill: "#324ab2"},
{source: "5: Financial Statements ", target: "5: market demands", fill: "#324ab2"},
{source: "5: market demands", target: "5: competition", fill: "#324ab2"},
{source: "5: competition", target: "5: active independent associates", fill: "#324ab2"},
{source: "5: factors affect", target: "8: use various", fill: "#ff6fff"},
{source: "8: use various", target: "8: address misconduct by", fill: "#ff6fff"},
{source: "8: address misconduct by", target: "8: misconduct", fill: "#ff6fff"},
{source: "8: misconduct", target: "8: independent", fill: "#ff6fff"},
{source: "8: independent", target: "8: associates", fill: "#ff6fff"},
{source: "8: associates", target: "8: independent associates", fill: "#ff6fff"},
{source: "8: independent associates", target: "8: conducting training seminars", fill: "#ff6fff"},
{source: "8: conducting training seminars", target: "8: still difficult", fill: "#ff6fff"},
{source: "8: use various", target: "9: Violations ", fill: "#c154c1"},
{source: "9: Violations ", target: "9: independent", fill: "#c154c1"},
{source: "9: independent", target: "9: associates", fill: "#c154c1"},
{source: "9: associates", target: "9: litigation", fill: "#c154c1"},
{source: "9: litigation", target: "9: complaints", fill: "#c154c1"},
{source: "9: complaints", target: "9: enforcement", fill: "#c154c1"},
{source: "9: enforcement", target: "9: regulatory", fill: "#c154c1"},
{source: "9: regulatory", target: "9: authorities", fill: "#c154c1"},
{source: "9: Violations ", target: "24: adverse publicity could", fill: "#e97451"},
{source: "24: adverse publicity could", target: "24: negatively affect", fill: "#e97451"},
{source: "24: negatively affect", target: "24: publics perception", fill: "#e97451"},
{source: "24: publics perception", target: "24: significant", fill: "#e97451"},
{source: "24: significant", target: "24: operations", fill: "#e97451"},
{source: "24: operations", target: "24: independent associates", fill: "#e97451"},
{source: "24: adverse publicity could", target: "31: manufacturers", fill: "#8c92ac"},
{source: "31: manufacturers", target: "31: adequate product liability insurance coverage", fill: "#8c92ac"},
{source: "31: manufacturers", target: "62: comply with government", fill: "#002395"},
{source: "62: comply with government", target: "62: regulations", fill: "#002395"},
{source: "62: regulations", target: "62: could suffer", fill: "#002395"},
{source: "62: comply with government", target: "START_HERE", fill: "#002395"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Ask for protection</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Travel to meet</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Covert monitoring</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Associated_Independent_Colleges">Associated Independent Colleges</a></td>
      <td>The Associated Independent Colleges, or AIC, is a group of independent secondary schools in south-east Queensland, Australia. With the exception of St Peters Lutheran College, AIC schools are all-boys schools (St Peter's secondary girls compete in the Queensland Girls' Secondary Schools Sports Association).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/N.F._Smith_&amp;_Associates">N.F. Smith &amp; Associates</a></td>
      <td>N.F. Smith &amp; Associates, also known as Smith, or Smith &amp; Associates, is an independent distributor of electronic components and semiconductors headquartered in Houston, Texas.\n\n\n== History ==\nIn 1984, brothers Robert and Leland Ackerley founded Smith, which  is the largest independent distributor of electronic components and ranks 7th among all global distributors, in the semiconductor and electronic components industry.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stock_market">Stock market</a></td>
      <td>A stock market, equity market, or share market is the aggregation of buyers and sellers of stocks (also called shares), which represent ownership claims on businesses; these may include securities listed on a public stock exchange, as well as stock that is only traded privately, such as shares of private companies which are sold to investors through equity crowdfunding platforms. Investment is usually made with an investment strategy in mind.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contents_insurance">Contents insurance</a></td>
      <td>Contents insurance is insurance that pays for damage to, or loss of, an individual’s personal possessions while they are located within that individual’s home. Some contents insurance policies also provide restricted cover for personal possessions temporarily taken away from the home by the policyholder.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Table_of_contents">Table of contents</a></td>
      <td>A table of contents, usually headed simply Contents and abbreviated informally as TOC, is a list, usually found on a page before the start of a written work, of its chapter or section titles or brief descriptions with their commencing page numbers.\n\n\n== History ==\nPliny the Elder credits Quintus Valerius Soranus (d.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Current_Contents">Current Contents</a></td>
      <td>Current Contents is a rapid alerting service database from Clarivate Analytics, formerly the Institute for Scientific Information and Thomson Reuters. It is published online and in several different printed subject sections.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Table_of_Contents_(Enochs)">Table of Contents (Enochs)</a></td>
      <td>Table of Contents is a sculpture designed by the American artist Dale Enochs. The sculpture is made from limestone and was commissioned by Joseph F. Miller.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Marc_Ecko's_Getting_Up:_Contents_Under_Pressure">Marc Ecko's Getting Up: Contents Under Pressure</a></td>
      <td>Marc Ecko's Getting Up: Contents Under Pressure is a video game released in February 2006 for PlayStation 2, Xbox, and Windows. It was developed by The Collective and published by Atari, Inc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contents_of_the_Book_of_Leinster">Contents of the Book of Leinster</a></td>
      <td>The following table of contents for the Book of Leinster is based on the diplomatic edition by R.I. Best and M.A. O'Brien. The contents are listed according to the folio number of the manuscript and the page and volume number of the edition.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Independent_clause">Independent clause</a></td>
      <td>An independent clause (or main clause) is a clause that can stand by itself as a simple sentence. An independent clause contains a subject and a predicate and makes sense by itself.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Irish_Independent">Irish Independent</a></td>
      <td>The Irish Independent is an Irish daily newspaper and online publication which is owned by Independent News &amp; Media (INM), a subsidiary of Mediahuis.\nThe newspaper version often includes glossy magazines.Traditionally a broadsheet newspaper, it introduced an additional compact size in 2004.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Independent_Baptist">Independent Baptist</a></td>
      <td>Independent Baptist churches (some also called Independent Fundamental Baptist or IFB) are Christian congregations, generally holding to conservative (primarily fundamentalist) Baptist beliefs. The term independent refers to the doctrinal position of church autonomy and a refusal to join any affiliated Baptist denomination, convention or hierarchical structure.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Independent_baseball_league">Independent baseball league</a></td>
      <td>An independent baseball league is a professional baseball organization in the United States or Canada that is not overseen by Major League Baseball and is outside the Minor League Baseball clubs affiliated to it.\nThe Northern League and Frontier League both started play in 1993, and the Northern League's success paved the way for other independent leagues like the Texas-Louisiana League and Northeast League.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Independent_school">Independent school</a></td>
      <td>An independent school is independent in its finances and governance. Also known as private schools, non-governmental, privately funded, or non-state schools, they are not administered by local, state or national governments.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Associate_degree">Associate degree</a></td>
      <td>An associate degree is an undergraduate degree awarded after a course of post-secondary study lasting two to three years. It is a level of qualification above a high school diploma, GED, or matriculation, and below a bachelor's degree.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Associated_Press">Associated Press</a></td>
      <td>The Associated Press (AP) is an American non-profit news agency headquartered in New York City. Founded in 1846, it operates as a cooperative, unincorporated association.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Johnny_&amp;_Associates">Johnny &amp; Associates</a></td>
      <td>Johnny &amp; Associates, Inc. (株式会社ジャニーズ事務所, Kabushiki-gaisha Janīzu Jimusho) is a Japanese talent agency, formed by Johnny Kitagawa in 1962, which trains and promotes groups of male entertainers known as Johnny's (ジャニーズ, Janīzu).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation">Regulation</a></td>
      <td>Regulation is the management of complex systems according to a set of rules and trends. In systems theory, these types of rules exist in various fields of biology and society, but the term has slightly different meanings according to context.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_modern_armament_manufacturers">List of modern armament manufacturers</a></td>
      <td>The following list of modern armament manufacturers presents major companies producing modern weapons and munitions for military, paramilitary, government agency and civilian use. The companies are listed by their full name followed by the short form, or common acronym, if any, in parentheses.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Original_equipment_manufacturer">Original equipment manufacturer</a></td>
      <td>An original equipment manufacturer (OEM) is generally perceived as a company that produces parts and equipment that may be marketed by another manufacturer.\nHowever, the term is also used in several other ways, which causes ambiguity.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Automotive_industry">Automotive industry</a></td>
      <td>The automotive industry comprises a wide range of companies and organizations involved in the design, development, manufacturing, marketing, and selling of motor vehicles. It is one of the world's largest industries by revenue (from 16 % such as in France up to 40 % to countries like Slovakia).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_automobile_manufacturers_of_Japan">List of automobile manufacturers of Japan</a></td>
      <td>This is a list of current and defunct automobile manufacturers of Japan.\n\n\n== Major current manufacturers ==\nHonda (1946–present)\nAcura (1986–present)\nHonda Verno (former dealer network)\nHonda Clio (former dealer network)\nIsuzu (1853–present; spun off from IHI in 1916)\nMazda (1920–present)\nAutorama (former dealer network)\nAutozam (former dealer network)\nEfini (former dealer network)\nEunos (former dealer network)\nXedos (former dealer network)\nMitsubishi (1873–1950; 1964–present)\nNissan (formerly Datsun) (1933–present)\nDatsun (formerly Kaishinsha Motorcar Works) (1925–1986; 2013–2022)\nKaishinsha Motorcar Works (1911–1925)\nInfiniti (1989–present)\nNissan Blue Stage (dealer network)\nNissan Red Stage (dealer network)\nNissan Cherry (dealer network, c.1970–2009)\nNissan Motor (dealer network, c.1968–2009)\nNissan Prince (dealer network, c.1968–2009)\nNissan Sunny/Satio (dealer network, c.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_price">List price</a></td>
      <td>The list price, also known as the manufacturer's suggested retail price (MSRP), or the recommended retail price (RRP), or the suggested retail price (SRP) of a product is the price at which its manufacturer notionally recommends that a retailer sell the product.\nSuggested pricing methods may conflict with competition theory, as they allow prices to be set higher than would be established by supply and demand.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_A">Regulation A</a></td>
      <td>In the United States under the Securities Act of 1933, any offer to sell securities must either be registered with the United States Securities and Exchange Commission (SEC) or meet certain qualifications to exempt it from such registration. Regulation A (or Reg A) contains rules providing exemptions from the registration requirements, allowing some companies to use equity crowdfunding to offer and sell their securities without having to register the securities with the SEC. Regulation A offerings are intended to make access to capital possible for small and medium-sized companies that could not otherwise bear the costs of a normal SEC registration and to allow nonaccredited investors to participate in the offering.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_(European_Union)">Regulation (European Union)</a></td>
      <td>A regulation is a legal act of the European Union that becomes immediately enforceable as law in all member states simultaneously. Regulations can be distinguished from directives which, at least in principle, need to be transposed into national law.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Codes,_Rules_and_Regulations">New York Codes, Rules and Regulations</a></td>
      <td>The New York Codes, Rules and Regulations (NYCRR) contains New York state rules and regulations. The NYCRR is officially compiled by the New York State Department of State's Division of Administrative Rules.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>MANNATECH INC      Item 1A Risk Factors        In addition to the other <font color="blue">risks described</font> in this report, the <font color="blue">following risk</font>     factors  should  be  considered  in evaluating our business and future     prospects:       1</td>
    </tr>
    <tr>
      <td>If we are unable to attract and retain <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>, our     business may suffer</td>
    </tr>
    <tr>
      <td>Our <font color="blue">future success depends largely upon</font> our ability to attract and retain a     large <font color="blue">active base</font> of <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and members who purchase and     sell our products</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot give</font> any assurances that the <font color="blue">productivity</font> of     our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and <font color="blue">members will continue at</font> their <font color="blue">current levels</font>     or increase in the future</td>
    </tr>
    <tr>
      <td>Several <font color="blue">factors affect</font> our ability to attract and     retain  a  <font color="blue">significant</font>  number  of <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and members,     including:           •   on-going motivation of our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>;           •   <font color="blue">general economic conditions</font>;           •   <font color="blue">significant</font> changes in the amount of <font color="blue">commissions paid</font>;           •   <font color="blue">public <font color="blue">perception</font></font> and <font color="blue">acceptance</font> of the <font color="blue">wellness industry</font>;           •   <font color="blue">public <font color="blue">perception</font></font> and <font color="blue">acceptance</font> of network-marketing;                                           22     ______________________________________________________________________    [93]Table of <font color="blue">Contents    </font>[94]Index to <font color="blue">Financial Statements       </font>  •   <font color="blue">public <font color="blue">perception</font></font> and <font color="blue">acceptance</font> of us and our products;           •   the limited number of people interested in pursuing network-marketing     as a business;           •   our ability to provide <font color="blue">proprietary</font> quality-driven products that the     <font color="blue">market demands</font>; and           •   <font color="blue">competition</font> in recruiting and retaining active <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font></td>
    </tr>
    <tr>
      <td>If  we incur substantial <font color="blue">liability</font> from <font color="blue">litigation</font>, <font color="blue">complaints</font>, or     <font color="blue"><font color="blue">enforcement</font> actions</font> resulting <font color="blue">from <font color="blue">misconduct</font> by</font> our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>,     our <font color="blue"><font color="blue">financial condition</font> <font color="blue">could suffer</font></font></td>
    </tr>
    <tr>
      <td>Although we <font color="blue">use various</font> means to <font color="blue">address <font color="blue">misconduct</font> by</font> our <font color="blue">in<font color="blue">dependent</font></font>     <font color="blue">associates</font>, including maintaining policies and procedures to govern the     conduct of our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and <font color="blue">conducting training seminars</font>, it     is  <font color="blue">still difficult</font> to detect and correct all instances of <font color="blue">misconduct</font></td>
    </tr>
    <tr>
      <td><font color="blue">Violations </font>of our policies and procedures by our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>     could  lead  to <font color="blue">litigation</font>, formal or informal <font color="blue">complaints</font>, <font color="blue">enforcement</font>     actions, and inquiries by various federal, state, or foreign <font color="blue">regulatory</font>     <font color="blue">authorities</font> against us and/or our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font></td>
    </tr>
    <tr>
      <td>Because we have     expanded  into  foreign countries, our policies and procedures for our     <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> differ due to the <font color="blue">different legal requirements</font> of     each  country  in  which  we  do business</td>
    </tr>
    <tr>
      <td>Litigation, <font color="blue">complaints</font>, and     <font color="blue">enforcement</font>  <font color="blue">actions involving us</font> and our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> could     consume considerable amounts of financial and other <font color="blue">corporate resources</font>,     <font color="blue">which could</font> have a <font color="blue">negative impact on</font> our business, <font color="blue">profitability</font> and growth     prospects</td>
    </tr>
    <tr>
      <td>Periodically, <font color="blue">regulatory</font> agencies have <font color="blue">inquired about certain</font>     <font color="blue">complaints</font>  regarding  our  <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>, and we have always     <font color="blue">cooperated with such inquiries</font> and <font color="blue">investigations</font></td>
    </tr>
    <tr>
      <td>If we are unable to protect our <font color="blue"><font color="blue">proprietary</font> rights</font> of our products, our     business <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>Our success and <font color="blue">competitive position largely depends on</font> our ability to     protect the following <font color="blue"><font color="blue">proprietary</font> rights</font>:           •   Ambrotose ™ complex, a <font color="blue">glyconutritional dietary supplement</font> ingredient     consisting of a blend of <font color="blue">plant polysaccharides</font> and used in the majority of     our products;           •   Ambroglycin^®, a balanced food-mineral matrix ingredient developed to     use the latest food science <font color="blue">technology</font> to provide various dietary     <font color="blue">supplements</font> to the body and used in Glycentials^® and Catalyst™; and           •   MTech AO Blend™, our <font color="blue">proprietary</font>, patent-pending antioxidant used in     Ambrotose AO^®</td>
    </tr>
    <tr>
      <td>We have <font color="blue">filed patent applications</font> for Ambrotose ™ complex in the United     States  and  certain other countries, and as of March 1, 2006, we have     received 20 patents for Ambrotose ™ <font color="blue">complex issued</font> in the <font color="blue"><font color="blue">United States</font> </font>and     19  various  foreign  countries</td>
    </tr>
    <tr>
      <td>In  addition,  we  have <font color="blue">entered into</font>     <font color="blue">confidentiality agreements with</font> our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>, suppliers,     <font color="blue">manufacturers</font>, <font color="blue">directors</font>, officers and <font color="blue">consultants</font> to <font color="blue">help protect</font> our     <font color="blue"><font color="blue">proprietary</font> rights</font></td>
    </tr>
    <tr>
      <td>Nevertheless, we continue to face the risk that our     patent protection for Ambrotose ™ <font color="blue">complex will</font> be denied or that the patent     protection we are granted is more limited <font color="blue">than originally requested</font></td>
    </tr>
    <tr>
      <td>As a     <font color="blue">precaution</font>, we consult with outside legal counsel and <font color="blue">consultants</font> to help     ensure that we <font color="blue">diligently</font> protect our <font color="blue"><font color="blue">proprietary</font> rights</font> to minimize this     risk</td>
    </tr>
    <tr>
      <td>However, our business, <font color="blue">profitability</font>, and <font color="blue"><font color="blue">growth prospects</font> could</font> be     <font color="blue">adversely</font>  affected  if  we fail to receive <font color="blue">adequate protection</font> of our     <font color="blue"><font color="blue">proprietary</font> rights</font></td>
    </tr>
    <tr>
      <td>If our business or our products are the subject of <font color="blue">adverse publicity</font>, our     business <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>Our business depends, in part, upon the public’s <font color="blue">perception</font> of our integrity     and the safety and quality of our products</td>
    </tr>
    <tr>
      <td>Any <font color="blue">adverse publicity</font> could     <font color="blue">negatively affect</font> the public’s <font color="blue">perception</font> and could result in a <font color="blue">significant</font>     decline in our <font color="blue">operations</font> and the number of our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font></td>
    </tr>
    <tr>
      <td>Specifically, we are susceptible to <font color="blue">adverse publicity</font> regarding:           •   the nutritional <font color="blue">supplements</font> industry;           •   <font color="blue">competitors</font>;           •   the safety and quality of our products and <font color="blue">ingredients</font>;                                           23     ______________________________________________________________________    [95]Table of <font color="blue">Contents    </font>[96]Index to <font color="blue">Financial Statements       </font>  •   <font color="blue">regulatory</font> <font color="blue">investigations</font> of our products or <font color="blue">competitors</font>’ products;           •   the actions of our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and the <font color="blue">management</font> of our     <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>; and           •   the <font color="blue">direct selling</font> and network-marketing industry</td>
    </tr>
    <tr>
      <td>If we are exposed to <font color="blue">product <font color="blue">liability</font></font> claims, we may be liable for     damages and expenses, <font color="blue">which could</font> affect our <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">could face financial <font color="blue">liability</font> due</font> to <font color="blue">product <font color="blue">liability</font></font> claims if the use     of our products results in <font color="blue">significant</font> loss or injury</td>
    </tr>
    <tr>
      <td>We make <font color="blue">no assurances</font>     that we will not be exposed to any substantial future <font color="blue">product <font color="blue">liability</font></font>     claims</td>
    </tr>
    <tr>
      <td>Such  claims  may  include  claims  that our <font color="blue">products contain</font>     <font color="blue">contaminants</font>, that we provide our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and <font color="blue">consumers with</font>     inadequate <font color="blue">instructions</font> regarding <font color="blue">product use</font>, or that we provide inadequate     <font color="blue">warnings concerning</font> side effects or <font color="blue">interactions</font> of our <font color="blue">products with</font> other     substances</td>
    </tr>
    <tr>
      <td>We  believe that our suppliers and <font color="blue">manufacturers</font> maintain     adequate <font color="blue">product <font color="blue">liability</font></font> insurance coverage</td>
    </tr>
    <tr>
      <td>However, a future product     <font color="blue">liability</font> claim could exceed the amount of insurance coverage or could be     excluded  under the terms of an existing insurance policy, <font color="blue">which could</font>     <font color="blue">adversely</font> affect our future <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>However, in 2002, we <font color="blue">voluntarily</font>     <font color="blue">discontinued</font> the sale of our <font color="blue">products contain</font>ing ephedra, which included two     of our products, GlycoLEAN^® Body System Accelerator™ and MVP In 2002, we     <font color="blue">voluntarily</font> <font color="blue">reformulate</font>d our GlycoLEAN^® Body System Accelerator™ to include     a non-ephedra ingredient and introduced GlycoLEAN^® Body System Accelerator     2™  and <font color="blue">discontinued</font> selling MVP None of our other products have ever     contained  ephedra</td>
    </tr>
    <tr>
      <td>During 2002, aggregate sales for our <font color="blue">discontinued</font>     products related to ephedra, were dlra1dtta2 million, which accounted for 0dtta9prca of     our <font color="blue"><font color="blue">consolidated</font> net sales</font> for the year ended <font color="blue">December </font>31, 2002</td>
    </tr>
    <tr>
      <td>In <font color="blue">recent years</font> a <font color="blue">discovery</font> of Bovine Spongiform Encephalopathy (“BSE”),     <font color="blue">commonly referred</font> to as “Mad Cow Disease” has caused concern among the     <font color="blue">general public</font></td>
    </tr>
    <tr>
      <td>As a result, some countries have banned the <font color="blue">importation</font> or     sale of products that contain bovine materials sourced from locations where     BSE has been identified</td>
    </tr>
    <tr>
      <td>We have <font color="blue">certain products</font> that use a beef-based     <font color="blue">gelatin capsule</font></td>
    </tr>
    <tr>
      <td>All of our <font color="blue">gelatin capsule</font>s are currently produced in the     <font color="blue"><font color="blue">United States</font> </font>or in Australia, which are considered BSE-free countries,     although a few cases have been identified in the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>Nonetheless,     we  <font color="blue">voluntarily</font>  began  to <font color="blue">switch certain</font> of our production to utilize     non-bovine <font color="blue">gelatin capsule</font>s that are vegetable-based rather than beef-based     in certain of our <font color="blue">capsule products</font> and are considering using vegetable-based     capsules in all <font color="blue">such products</font></td>
    </tr>
    <tr>
      <td>However, <font color="blue">future government action could</font>     require companies to use vegetable-based capsules, and if required, the     costs of vegetable-based capsules could increase our <font color="blue">costs as compared</font> to     the  costs of bovine-based capsules</td>
    </tr>
    <tr>
      <td>The <font color="blue">higher costs could affect</font> our     <font color="blue">financial condition</font>, results of <font color="blue">operations</font>, and our <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">outside suppliers</font> and <font color="blue">manufacturers</font> fail to <font color="blue">supply products</font> in     <font color="blue">sufficient quantities</font> and in a <font color="blue">timely fashion</font>, our business <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>Outside <font color="blue">manufacturers</font> make all of our products</td>
    </tr>
    <tr>
      <td>During 2004 and 2005, our     <font color="blue">manufacturers</font> and we collectively purchased approximately, 47prca and 33prca,     <font color="blue">respectively</font>, of a supplier’s supply of Manapol^® and purchased 100prca for     both years of a supplier’s Australia Plum Powder, which is used in our     <font color="blue">Ambrotose  </font>AO^®  product</td>
    </tr>
    <tr>
      <td>We also purchased approximately 30prca and 39prca,     <font color="blue">respectively</font> of a manufacturer’s production of finished products for the     years ended <font color="blue">December </font>31, 2004 and 2005, <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">profit margins</font> and     timely  <font color="blue">product delivery</font> are <font color="blue"><font color="blue">dependent</font> upon</font> the ability of our outside     suppliers and <font color="blue">manufacturers</font> to <font color="blue">supply us with products</font> in a timely and     cost-efficient  manner</td>
    </tr>
    <tr>
      <td>Our  ability to <font color="blue">enter new markets</font> and sustain     satisfactory levels of sales in <font color="blue">each market depends upon</font> the ability of our     <font color="blue">outside suppliers</font> and <font color="blue">manufacturers</font> to produce the <font color="blue">ingredients</font> and products     and to <font color="blue">comply with</font> all <font color="blue">applicable <font color="blue">regulations</font></font></td>
    </tr>
    <tr>
      <td>As a <font color="blue">precaution</font>, we have     approved alternate suppliers and <font color="blue">manufacturers</font> for our products</td>
    </tr>
    <tr>
      <td>However,     the failure of our primary suppliers or <font color="blue">manufacturers</font> to supply <font color="blue">ingredients</font>     or produce our products could <font color="blue">adversely</font> affect our business <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>24     ______________________________________________________________________    [97]Table of <font color="blue">Contents    </font>[98]Index to <font color="blue">Financial Statements       </font>We believe we have <font color="blue">dependable suppliers</font> for all of our <font color="blue">ingredients</font> and that     we have identified <font color="blue">alternative sources</font> for all of our <font color="blue">ingredients</font> except     Arabinogalactan, which is a component of our <font color="blue">proprietary</font> compound</td>
    </tr>
    <tr>
      <td><font color="blue">Although     </font>we maintain good <font color="blue">relationships with</font> our suppliers and could produce or     <font color="blue">replace certain</font> of our <font color="blue">ingredients</font> if our suppliers are unable to perform,     any delay in replacing or substituting such <font color="blue">ingredients</font> could affect our     business</td>
    </tr>
    <tr>
      <td>The  global  nutrition  industry  is <font color="blue">intensely competitive</font> and the     <font color="blue">strengthening</font> of any of our <font color="blue">competitors</font> could harm our business</td>
    </tr>
    <tr>
      <td>The <font color="blue">global nutrition industry</font> is <font color="blue">intensely competitive</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">also compete</font> for     <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> with other network-marketing companies outside the     <font color="blue">global nutrition industry</font></td>
    </tr>
    <tr>
      <td>Many <font color="blue">competitors</font> have <font color="blue">greater name recognition</font>     and financial resources, which may give them a <font color="blue">competitive advantage</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">competitors</font> may also be able to <font color="blue">devote greater resources</font> to marketing,     promotional, and <font color="blue">pricing campaigns</font> that <font color="blue">may influence</font> our continuing and     potential  <font color="blue">in<font color="blue">dependent</font></font>  <font color="blue">associates</font>  and  members  to <font color="blue">buy products from</font>     <font color="blue">competitors</font> rather than from us</td>
    </tr>
    <tr>
      <td>Such <font color="blue">competition</font> could <font color="blue">adversely</font> affect our     business and <font color="blue">current market</font> share</td>
    </tr>
    <tr>
      <td>If  our network-marketing <font color="blue">activities</font> do not <font color="blue">comply with</font> government     <font color="blue">regulations</font>, our business <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>A government agency’s determination that our business and/or our <font color="blue">in<font color="blue">dependent</font></font>     <font color="blue">associates</font> have <font color="blue">significant</font>ly violated a law or regulation could <font color="blue">adversely</font>     affect our business</td>
    </tr>
    <tr>
      <td>The laws and <font color="blue">regulations</font> regulating network-marketing     <font color="blue">generally intend</font> to <font color="blue">prevent fraudulent</font> or <font color="blue">deceptive schemes</font></td>
    </tr>
    <tr>
      <td>Our business     faces constant <font color="blue">regulatory</font> scrutiny due to the <font color="blue">interpretive</font> and <font color="blue">enforcement</font>     <font color="blue">discretion given</font> to regulators, periodic <font color="blue">misconduct</font> by our <font color="blue">in<font color="blue">dependent</font></font>     <font color="blue">associates</font>,  adoption  of  new laws or <font color="blue">regulations</font>, and changes in the     <font color="blue">interpretation</font> of new or <font color="blue">existing laws</font> or <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In the past, we have     experienced inquiries regarding specific <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font> and have     complied and cooperated with all <font color="blue">regulatory</font> agencies in <font color="blue">connection</font> with such     inquiries</td>
    </tr>
    <tr>
      <td>If government <font color="blue">regulations</font> regarding network-marketing systems change or     if interpreted or enforced in a <font color="blue">manner adverse</font> to our business, we may be     subject to new <font color="blue"><font color="blue">enforcement</font> actions</font> and material <font color="blue">limitations</font> regarding our     business <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our network-marketing system is always subject to extensive <font color="blue">governmental</font>     <font color="blue">regulations</font>, including foreign, federal, and state <font color="blue">regulations</font> regarding     network-marketing companies</td>
    </tr>
    <tr>
      <td>Any <font color="blue">detrimental</font> change in <font color="blue">legislation</font> and     <font color="blue">regulations</font> could affect our business</td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">significant</font> penalties     could be <font color="blue">imposed upon us</font> for failure to <font color="blue">comply with</font> various statutes or     <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Violations </font>may result from:           •   <font color="blue">misconduct</font> by our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>;           •   <font color="blue">ambiguity</font> in statutes;           •   <font color="blue">regulations</font> and related <font color="blue">court decisions</font>;           •   the <font color="blue">discretion afforded</font> to <font color="blue">regulatory</font> <font color="blue">authorities</font> and courts     <font color="blue">interpreting</font> and <font color="blue">enforcing laws</font>; and           •   <font color="blue">regulations</font> affecting our business</td>
    </tr>
    <tr>
      <td>If  we violate various <font color="blue">governmental</font> <font color="blue">regulations</font> or fail to obtain     necessary <font color="blue">regulatory</font> approvals, our <font color="blue">operations</font> could be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>Our  operation is subject to extensive laws, <font color="blue">governmental</font> <font color="blue">regulations</font>,     administrative determinations, <font color="blue">court decisions</font>, and similar <font color="blue">constraints at</font>     the federal, state, and <font color="blue">local levels</font> in our domestic and <font color="blue">foreign markets</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font> primarily involve the following:           •   the formulation, manufacturing, packaging, labeling, <font color="blue">distribution</font>,     <font color="blue">importation</font>, sale, and storage of our products;           •   the health and safety of food and dietary <font color="blue">supplements</font>;                                           25     ______________________________________________________________________    [99]Table of <font color="blue">Contents    </font>[100]Index to <font color="blue">Financial Statements       </font>  •   <font color="blue">trade practice laws</font> and network-marketing laws;           •   our product claims and <font color="blue">advertising by</font> our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>;           •   our network-marketing system;           •   <font color="blue">pricing restrictions</font> regarding <font color="blue"><font color="blue">transaction</font>s with</font> our foreign     <font color="blue">subsidiaries</font> or other related parties and similar <font color="blue">regulations</font> that affect     our level of <font color="blue">foreign taxable income</font>;           •   the <font color="blue">assessment</font> of <font color="blue">customs duties</font>;           •   <font color="blue">further taxation</font> of our <font color="blue"><font color="blue">in<font color="blue">dependent</font></font> <font color="blue">associates</font></font>, which may obligate us     to <font color="blue">collect additional taxes</font> and maintain <font color="blue">additional records</font>; and           •   export and <font color="blue">import restrictions</font></td>
    </tr>
    <tr>
      <td>Any unexpected new <font color="blue">regulations</font> or changes in existing <font color="blue">regulations</font> could     <font color="blue">significant</font>ly restrict our ability to continue <font color="blue">operations</font>, <font color="blue">which could</font>     <font color="blue">adversely</font> affect our business</td>
    </tr>
    <tr>
      <td>For example, changes regarding health and     safety, and food and drug <font color="blue">regulations</font> for our <font color="blue">nutritional products could</font>     require us to <font color="blue">reformulate</font> our products to <font color="blue">comply with</font> such <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In some foreign countries, nutritional products are considered foods, while     other countries consider <font color="blue">them drugs</font></td>
    </tr>
    <tr>
      <td>Future health and safety, or food and     drug, <font color="blue">regulations</font> could delay or prevent our introduction of <font color="blue">new products</font> or     suspend or prohibit the sale of <font color="blue">existing products</font> in a <font color="blue">given country</font> or     marketplace</td>
    </tr>
    <tr>
      <td>In addition, if we <font color="blue">expand into</font> other <font color="blue">foreign markets</font>, our     <font color="blue">operations</font> or products could also be <font color="blue">affected by</font> the <font color="blue">general stability</font> of     foreign   <font color="blue">governments</font>  and  the  <font color="blue">regulatory</font>  <font color="blue">environment</font>  relating  to     network-marketing and our products</td>
    </tr>
    <tr>
      <td>If our products are subject to high     <font color="blue">customs duties</font>, our sales and competitive position <font color="blue">could suffer</font> as compared     to locally produced goods</td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">import restrictions</font> in certain     countries and <font color="blue">jurisdictions could limit</font> our ability to <font color="blue">import products from</font>     the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">international markets</font> are not successful, our business could     suffer</td>
    </tr>
    <tr>
      <td>We currently operate in the <font color="blue">international markets</font> of Canada, Australia, the     United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, and     Denmark</td>
    </tr>
    <tr>
      <td>We are <font color="blue">also registering</font> our products in Germany</td>
    </tr>
    <tr>
      <td>Nonetheless, our     international <font color="blue">operations</font> could experience changes in legal and <font color="blue">regulatory</font>     requirements, as well as difficulties in adapting to <font color="blue">new foreign cultures</font>     and business customs</td>
    </tr>
    <tr>
      <td>If we do not <font color="blue">adequately address such issues</font>, our     <font color="blue">international markets</font> may not <font color="blue">meet growth expectations</font></td>
    </tr>
    <tr>
      <td>Our international     <font color="blue">operations</font> and <font color="blue">future expansion</font> plans are subject to political, economic,     and <font color="blue">social uncertainties</font>, including:           •   inflation;           •   the <font color="blue">renegotiation</font> or <font color="blue">modification</font> of <font color="blue">various agreements</font>;           •   increases in <font color="blue">custom duties</font> and tariffs;           •   changes and limits in <font color="blue">export controls</font>;           •   government <font color="blue">regulations</font> and laws;           •   <font color="blue">trademark availability</font> and <font color="blue">registration issues</font>;           •   changes in <font color="blue"><font color="blue">exchange rate</font>s</font>;           •   changes in taxation;           •   wars and other <font color="blue">hostilities</font>; and           •   changes in the <font color="blue">perception</font> of network-marketing</td>
    </tr>
    <tr>
      <td>Any negative changes related to these factors could <font color="blue">adversely</font> affect our     business, <font color="blue">profitability</font>, and <font color="blue">growth prospects</font></td>
    </tr>
    <tr>
      <td>Furthermore, changes in our     <font color="blue">distribution</font> channels may force us to invest <font color="blue">significant</font> time and money     related to our <font color="blue">distribution</font> and sales to maintain our position in certain     <font color="blue">international markets</font></td>
    </tr>
    <tr>
      <td>26     ______________________________________________________________________    [101]Table of <font color="blue">Contents    </font>[102]Index to <font color="blue">Financial Statements       </font>12</td>
    </tr>
    <tr>
      <td>If our information <font color="blue">technology</font> system fails, our <font color="blue">operations</font> <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>Our  business  is  heavily  <font color="blue">dependent</font>  upon our information <font color="blue">technology</font>     <font color="blue">infrastructure</font> to <font color="blue">effectively manage</font> and operate many of our key business     functions, including:           •   order processing;           •   <font color="blue">customer service</font>;           •   product <font color="blue">distribution</font>;           •   <font color="blue">commission processing</font>;           •   <font color="blue">cash receipts</font> and payments; and           •   financial reporting</td>
    </tr>
    <tr>
      <td>Although we maintain an extensive <font color="blue">disaster recovery program</font>, a long-term     failure or <font color="blue">impairment</font> of any of our information <font color="blue">technology</font> systems could     <font color="blue">adversely</font> affect our ability to conduct day-to-day business</td>
    </tr>
    <tr>
      <td>Currency <font color="blue"><font color="blue">exchange rate</font> <font color="blue">fluctuations</font> could lower</font> our revenue and net     income</td>
    </tr>
    <tr>
      <td>In 2004 and 2005, we recognized 34dtta6prca and 33dtta4prca, <font color="blue">respectively</font>, of our net     sales in <font color="blue">markets outside</font> of the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>In preparing our <font color="blue">consolidated</font>     financial  statements, various financial information is required to be     <font color="blue">translated from foreign currencies</font> to the <font color="blue"><font color="blue">United States</font> </font><font color="blue">dollar using either</font>     the spot rate or the weighted-average <font color="blue">exchange rate</font></td>
    </tr>
    <tr>
      <td>If the <font color="blue"><font color="blue">United States</font> </font>    <font color="blue">dollar strengthens relative</font> to applicable local currencies, there is a risk     our reported sales, operating expenses, and net income could <font color="blue">significant</font>ly     fluctuate</td>
    </tr>
    <tr>
      <td>We  are  not  able  to predict the degree of <font color="blue">exchange rate</font>     <font color="blue">fluctuations</font>, nor can we estimate the effect any <font color="blue">future <font color="blue">fluctuations</font> may</font>     have upon our future <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>However, to help mitigate this risk, our     <font color="blue">management</font> monitors applicable <font color="blue"><font color="blue">exchange rate</font>s</font></td>
    </tr>
    <tr>
      <td>To date we have not entered     into any hedging contracts or <font color="blue"><font color="blue">participate</font>d</font> in any hedging or <font color="blue">derivative</font>     <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>Our stock price could fluctuate <font color="blue">significant</font>ly</td>
    </tr>
    <tr>
      <td>The price of our <font color="blue">common stock</font> is subject to sudden and material increases     and <font color="blue">decreases</font></td>
    </tr>
    <tr>
      <td><font color="blue">Decreases </font>could <font color="blue">adversely</font> affect investments in our common     stock</td>
    </tr>
    <tr>
      <td>The price of our <font color="blue">common stock</font> and the <font color="blue">price at which</font> we <font color="blue">could sell</font>     securities in the future could <font color="blue">significant</font>ly fluctuate in response to:           •   <font color="blue">broad market <font color="blue">fluctuations</font></font> and <font color="blue">general economic conditions</font>;           •   <font color="blue">fluctuations</font> in our financial results;           •   <font color="blue">future securities offerings</font>;           •   changes in the market’s <font color="blue">perception</font> of our products or our business;           •   <font color="blue">governmental</font> <font color="blue">regulatory</font> actions;           •   the outcome of any lawsuits;           •   financial and business <font color="blue">announcements</font> made by us or our <font color="blue">competitors</font>;     and           •   the <font color="blue">general condition</font> of the economy and industry</td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">stock market</font> has experienced <font color="blue">extreme price</font> and volume     <font color="blue">fluctuations</font> in <font color="blue">recent years</font> that have <font color="blue">significant</font>ly affected the quoted     prices of the securities of many companies</td>
    </tr>
    <tr>
      <td>The price of our     <font color="blue">common stock</font> in the <font color="blue">open market could fluctuate based on factors</font> that have     little or nothing to do with us or that are outside of our control</td>
    </tr>
    <tr>
      <td>27     ______________________________________________________________________    [103]Table of <font color="blue">Contents    </font>[104]Index to <font color="blue">Financial Statements       </font>15</td>
    </tr>
    <tr>
      <td>Certain <font color="blue">shareholders</font>, <font color="blue">directors</font>, and officers own a <font color="blue">significant</font> amount     of our stock, <font color="blue">which could</font> allow them to <font color="blue">influence corporate <font color="blue">transaction</font>s</font> and     other matters</td>
    </tr>
    <tr>
      <td>As of <font color="blue">December </font>31, 2005, our <font color="blue">directors</font> and executive officers, collectively     with their families and affiliates, beneficially owned approximately 40dtta5prca     of  our  total  outstanding <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>As a result, if any of these     <font color="blue">shareholders</font> choose to act <font color="blue">together based on</font> their current share ownership,     they may be able to control a <font color="blue">significant</font> amount of shares of our stock,     <font color="blue">which could</font> affect the outcome of a <font color="blue">shareholder vote on</font> the election of     <font color="blue">directors</font>, the adoption of <font color="blue">stock option</font> plans, the adoption or <font color="blue">amendment</font> of     provisions in our articles of <font color="blue">incorporation</font> and bylaws, or the approval of     mergers and other <font color="blue">significant</font> corporate <font color="blue">transaction</font>s</td>
    </tr>
    <tr>
      <td>We have implemented anti-takeover provisions that <font color="blue">may help discourage</font> a     change of control</td>
    </tr>
    <tr>
      <td>Certain provisions in our articles of <font color="blue">incorporation</font>, bylaws, and the Texas     Business Corporation Act <font color="blue">help discourage unsolicited proposals</font> to acquire     our company, even if the <font color="blue">proposal may benefit</font> our <font color="blue">shareholders</font></td>
    </tr>
    <tr>
      <td>Our articles     of  <font color="blue">incorporation</font>  authorize  the  issuance of <font color="blue"><font color="blue">preferred stock</font> without</font>     <font color="blue">shareholder approval</font></td>
    </tr>
    <tr>
      <td><font color="blue">Our Board of <font color="blue">Directors </font></font>has the power to determine the     price  and  terms  of any <font color="blue">preferred stock</font></td>
    </tr>
    <tr>
      <td>The ability of our Board of     <font color="blue"><font color="blue">Directors </font> </font>to  issue  one  or  more  series of <font color="blue"><font color="blue">preferred stock</font> without</font>     <font color="blue">shareholders</font>’ approval could deter or delay unsolicited changes of control     by  <font color="blue">discouraging</font>  open  market  purchases  of  our  common  stock or a     non-negotiated tender or <font color="blue">exchange offer</font> for our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td><font color="blue">Discouraging     </font><font color="blue">open market purchases may</font> be <font color="blue">disadvantageous</font> to our <font color="blue">shareholders</font> who may     otherwise desire to <font color="blue">participate</font> in a <font color="blue">transaction</font> in which they would receive     a premium for their shares</td>
    </tr>
    <tr>
      <td>In addition, other <font color="blue">provisions may also discourage</font> a change of <font color="blue">control by</font>     means of a tender offer, open market purchase, proxy contest or otherwise</td>
    </tr>
    <tr>
      <td>Our <font color="blue">charter documents provide</font> for <font color="blue">three classes</font> of <font color="blue">directors</font> on our Board of     <font color="blue">Directors </font><font color="blue">with members</font> of each class <font color="blue">serving staggered three year terms</font></td>
    </tr>
    <tr>
      <td>Also, the Texas Business Corporation Act restricts, subject to <font color="blue">exceptions</font>,     business <font color="blue">combinations with</font> any “<font color="blue">affiliated shareholder</font></td>
    </tr>
  </tbody>
</table>